Cargando…
(1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs)
Invasive fungal infections (IFIs) are serious and often life-threatening complications in patients with haematological malignancies. Early diagnosis and the initiation of efficacious antifungal treatments could affect the prognosis of these patients. The detection of (1-3)-β-D-Glucan (BDG) could be...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431562/ https://www.ncbi.nlm.nih.gov/pubmed/22942923 http://dx.doi.org/10.2174/1874285801206010070 |
_version_ | 1782242098783715328 |
---|---|
author | Fontana, C Gaziano, R Favaro, M Casalinuovo, IA Pistoia, ES Di Francesco, P |
author_facet | Fontana, C Gaziano, R Favaro, M Casalinuovo, IA Pistoia, ES Di Francesco, P |
author_sort | Fontana, C |
collection | PubMed |
description | Invasive fungal infections (IFIs) are serious and often life-threatening complications in patients with haematological malignancies. Early diagnosis and the initiation of efficacious antifungal treatments could affect the prognosis of these patients. The detection of (1-3)-β-D-Glucan (BDG) could be a promising non-culture-based, noninvasive tool for IFI analyses in haemato-oncological patients, allowing the diagnosis of the two major IFIs, invasive aspergillosis (IA) and invasive candidiasis (IC), with a single test. The aim of this work was to evaluate and compare the use of the BDG in combination with the galactomannan antigen (GAL) assay in order to exclude or confirm suspected IFIs. Sera from 46 haemato-oncological patients (24 with proven/probable IFI and 22 without IFI symptoms) were evaluated retrospectively for the detection of GAL and BDG. In 24 patients, the serum BDG levels facilitated IFI diagnosis: 18 probable IA, 3 proven IA and 3 IC. In the remaining 22 patients, the BDG level helped exclude IFIs. The BDG was positive earlier than GAL in 5/24 cases [three of probable invasive aspergillosis (IA), one of proven IA and one case of proven invasive candidiasis (IC)] and was positive at the same time as GAL in 19/24 cases; in no case was GAL positive before BDG was. The BDG detection is useful, however, the test has a great limitation because it is a completely manual procedure. |
format | Online Article Text |
id | pubmed-3431562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Bentham Open |
record_format | MEDLINE/PubMed |
spelling | pubmed-34315622012-08-31 (1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs) Fontana, C Gaziano, R Favaro, M Casalinuovo, IA Pistoia, ES Di Francesco, P Open Microbiol J Article Invasive fungal infections (IFIs) are serious and often life-threatening complications in patients with haematological malignancies. Early diagnosis and the initiation of efficacious antifungal treatments could affect the prognosis of these patients. The detection of (1-3)-β-D-Glucan (BDG) could be a promising non-culture-based, noninvasive tool for IFI analyses in haemato-oncological patients, allowing the diagnosis of the two major IFIs, invasive aspergillosis (IA) and invasive candidiasis (IC), with a single test. The aim of this work was to evaluate and compare the use of the BDG in combination with the galactomannan antigen (GAL) assay in order to exclude or confirm suspected IFIs. Sera from 46 haemato-oncological patients (24 with proven/probable IFI and 22 without IFI symptoms) were evaluated retrospectively for the detection of GAL and BDG. In 24 patients, the serum BDG levels facilitated IFI diagnosis: 18 probable IA, 3 proven IA and 3 IC. In the remaining 22 patients, the BDG level helped exclude IFIs. The BDG was positive earlier than GAL in 5/24 cases [three of probable invasive aspergillosis (IA), one of proven IA and one case of proven invasive candidiasis (IC)] and was positive at the same time as GAL in 19/24 cases; in no case was GAL positive before BDG was. The BDG detection is useful, however, the test has a great limitation because it is a completely manual procedure. Bentham Open 2012-08-24 /pmc/articles/PMC3431562/ /pubmed/22942923 http://dx.doi.org/10.2174/1874285801206010070 Text en © Fontana et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Fontana, C Gaziano, R Favaro, M Casalinuovo, IA Pistoia, ES Di Francesco, P (1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs) |
title | (1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs) |
title_full | (1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs) |
title_fullStr | (1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs) |
title_full_unstemmed | (1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs) |
title_short | (1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs) |
title_sort | (1-3)-β-d-glucan vs galactomannan antigen in diagnosing invasive fungal infections (ifis) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431562/ https://www.ncbi.nlm.nih.gov/pubmed/22942923 http://dx.doi.org/10.2174/1874285801206010070 |
work_keys_str_mv | AT fontanac 13bdglucanvsgalactomannanantigenindiagnosinginvasivefungalinfectionsifis AT gazianor 13bdglucanvsgalactomannanantigenindiagnosinginvasivefungalinfectionsifis AT favarom 13bdglucanvsgalactomannanantigenindiagnosinginvasivefungalinfectionsifis AT casalinuovoia 13bdglucanvsgalactomannanantigenindiagnosinginvasivefungalinfectionsifis AT pistoiaes 13bdglucanvsgalactomannanantigenindiagnosinginvasivefungalinfectionsifis AT difrancescop 13bdglucanvsgalactomannanantigenindiagnosinginvasivefungalinfectionsifis |